Membrane homeostasis in adipose physiology and obesity
Membrane homeostasis in adipose physiology and obesity
批准号:
10611472
负责人:
PETER J TONTONOZ
金额:
$47.06万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-22 至 2025-04-30
关键词:
AcidsAddressAdipocytesAdipose tissueAffectAnimalsArachidonic AcidsAutomobile DrivingBioenergeticsBrown FatCatabolismCell NucleusCellsCellular MorphologyCollaborationsDataDefectDiabetes MellitusDietDietary FatsDietary Fatty AcidEnergy MetabolismEnvironmentEnzymesEquilibriumExposure toFGF21 geneGene ExpressionGoalsHepaticHigh Fat DietHomeostasisIntakeKnockout MiceLaboratoriesLinkLinoleic AcidsLipidsMediatorMembraneMembrane LipidsMetabolicMetabolic DiseasesMitochondriaModelingMorphologyMusNutrientObesityOrganellesPathologicPathway interactionsPhenotypePhospholipidsPhysiologicalPhysiologyPolyunsaturated Fatty AcidsPopulationPredispositionProcessProductionPublishingRegulationRegulatory PathwayResistanceRespirationRoleSignal TransductionStressTestingTimeTissue ExpansionTissue membraneTissuesUp-Regulationadipocyte differentiationbiological adaptation to stressdetection of nutrientdiet-induced obesitydietarydietary excessendoplasmic reticulum stressenergy balancefatty acid oxidationfibroblast growth factor 21genetic manipulationinterestloss of functionmitochondrial membranemouse modelnovelobesity developmentobesogenicoxidationpatch clampresponsethermal stress
中文摘要
摘要
我们实验室的一个主要长期目标是描述控制脂肪细胞的调节机制,
发育和系统生理学。该提案将涉及一种新的监管途径,
脂肪细胞营养感测、脂肪组织生理学和脂肪库特异性能量消耗。的
建议的研究集中在了解如何动态调节脂肪细胞膜组成
有助于控制活体动物的全身代谢稳态。初步数据显示
磷脂重塑酶Lpcat 3作为膳食脂肪酸摄入之间的新机制联系,
脂肪组织稳态和对肥胖的易感性。这一建议建立在我们初步的
解决有关膜脂组成与
脂肪组织功能和全身生理和能量平衡。我们之前已经证明,
酶Lpcat 3是将β 6多不饱和脂肪酸掺入到
磷脂我们的初步数据显示,脂肪Lpcat3表达在寒冷环境中被诱导,
暴露或饮食引起的肥胖。此外,选择性缺乏Lpcat 3的小鼠的初步特征
脂肪组织揭示了两种不同的表型:一种追溯到白色脂肪组织(WAT),
棕色脂肪组织(BAT)。高脂饮食喂养的脂肪Lpcat3 KO小鼠发生脂肪营养不良
表型不能适当地扩大他们的WAT,导致异位肝脂质积聚,
WAT中脂肪酸氧化的补偿性上调。与此同时,BAT Lpcat3 KO小鼠显示出
对冷刺激的异常反应,以显著的ER应激为特征。一个惊人的共同点,
这些WAT和BAT KO模型是FGF21的补偿性生产,显然是为了维持
能量平衡我们假设Lpcat3对脂肪组织膜组成的微调
是对寒冷和饮食挑战的关键适应性反应,允许最佳的脂质储存和分解代谢
在一系列环境中发挥作用。我们将讨论这些假设与以下具体目标。
具体目标1是阐明膜磷脂重塑在营养感受和健康中的作用。
脂肪组织扩张术具体目标2是确定磷脂重塑在BAT功能中的作用
和对热应力的反应。
英文摘要
ABSTRACT
A major long-term goal of our laboratory is to delineate regulatory mechanisms that control adipocyte
development and systemic physiology. This proposal will address a new regulatory pathway involved in
adipocyte nutrient sensing, adipose tissue physiology, and adipose depot-specific energy expenditure. The
proposed studies are focused on understanding how dynamic regulation adipocyte membrane composition
contributes to the control of whole-body metabolic homeostasis in living animals. Preliminary data implicates
the phospholipid remodeling enzyme Lpcat3 as novel mechanistic link between dietary fatty acid intake,
adipose tissue homeostasis, and susceptibility to obesity. This proposal builds upon our preliminary
discoveries to address important questions regarding the relationship of membrane lipid composition to
adipose tissue function and systemic physiology and energy balance. We have previously shown that the
enzyme Lpcat3 is uniquely required for the incorporation of the 6 polyunsaturated fatty acids into
phospholipids. Our preliminary data reveal that adipose Lpcat3 expression is induced in the setting of cold
exposure or diet-induced obesity. Moreover, initial characterization of mice lacking Lpcat3 selectively in
adipose tissues has revealed two distinct phenotypes: one traced to white adipose tissue (WAT) and one
traced to brown adipose tissue (BAT). Adipose Lpcat3 KO mice fed a high-fat diet develop a lipodystrophic
phenotype are unable to appropriately expand their WAT, leading to ectopic hepatic lipid accumulation and the
compensatory upregulation of fatty acid oxidation in WAT. At the same time, BAT Lpcat3 KO mice show an
abnormal response to cold challenge, characterized by marked ER stress. A striking commonality between
these WAT and BAT KO models is the compensatory production of FGF21 in an apparent effort to maintain
energy homeostasis. We hypothesize that the fine tuning of adipose tissue membrane composition by Lpcat3
is a critical adaptive response to cold and dietary challenge that permits optimal lipid storage and catabolic
function in a range of environments. We will address these hypotheses with the following specific aims.
Specific Aim 1 is to elucidate the role of membrane phospholipid remodeling in nutrient sensing and healthy
adipose tissue expansion. Specific Aim 2 is to determine the role of phospholipid remodeling in BAT function
and response to thermal stress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid storage and utilization in physiology and obesity
-
批准号:10663760
-
项目类别:
-
资助金额:$55.38万
-
财政年份:2023
-
负责人:PETER J TONTONOZ
-
依托单位:
Membrane homeostasis in adipose physiology and obesity
-
批准号:10455597
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2021
-
负责人:PETER J TONTONOZ
-
依托单位:
Membrane homeostasis in adipose physiology and obesity
-
批准号:10276825
-
项目类别:
-
资助金额:$48.46万
-
财政年份:2021
-
负责人:PETER J TONTONOZ
-
依托单位:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
-
批准号:10094838
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2020
-
负责人:PETER J TONTONOZ
-
依托单位:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
-
批准号:10437873
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2020
-
负责人:PETER J TONTONOZ
-
依托单位:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
-
批准号:10263359
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2020
-
负责人:PETER J TONTONOZ
-
依托单位:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
-
批准号:10654700
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2020
-
负责人:PETER J TONTONOZ
-
依托单位:
Immune pathways in adipose thermogenesis
-
批准号:10460987
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2019
-
负责人:PETER J TONTONOZ
-
依托单位:
Cellular cholesterol movement in cardiovascular disease
-
批准号:10161853
-
项目类别:
-
资助金额:$67.08万
-
财政年份:2019
-
负责人:PETER J TONTONOZ
-
依托单位:
Cellular cholesterol movement in cardiovascular disease
-
批准号:10397415
-
项目类别:
-
资助金额:$67.08万
-
财政年份:2019
-
负责人:PETER J TONTONOZ
-
依托单位:
Immune pathways in adipose thermogenesis
-
批准号:10222662
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2019
-
负责人:PETER J TONTONOZ
-
依托单位:
Immune pathways in adipose thermogenesis
-
批准号:10019525
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2019
-
负责人:PETER J TONTONOZ
-
依托单位:
Cellular cholesterol movement in cardiovascular disease
-
批准号:10613974
-
项目类别:
-
资助金额:$67.08万
-
财政年份:2019
-
负责人:PETER J TONTONOZ
-
依托单位:
Lipid-Responsive E3 ubiquitin ligases in cholesterol metabolism and atheroscierosis
-
批准号:10062512
-
项目类别:
-
资助金额:$51.48万
-
财政年份:2018
-
负责人:PETER J TONTONOZ
-
依托单位:
Regulation of Lipid Metabolism and Inflammation by the Orphan Nuclear Receptors
-
批准号:7647666
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2009
-
负责人:PETER J TONTONOZ
-
依托单位:
Novel Pathways for Triglyceride Storage and Adipogenesis
-
批准号:7898773
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2009
-
负责人:PETER J TONTONOZ
-
依托单位:
Novel Pathways for Triglyceride Storage and Adipogenesis
-
批准号:7537504
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2008
-
负责人:PETER J TONTONOZ
-
依托单位:
Novel Pathways for Triglyceride Storage and Adipogenesis
-
批准号:8786456
-
项目类别:
-
资助金额:$52.89万
-
财政年份:2008
-
负责人:PETER J TONTONOZ
-
依托单位:
Role of PPARdelta in Lipid Metabolism /Atherosclerosis
-
批准号:6758078
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2003
-
负责人:PETER J TONTONOZ
-
依托单位:
PILOT AND FEASIBILITY PROGRAM
-
批准号:8913138
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2003
-
负责人:PETER J TONTONOZ
-
依托单位:
海外基金